Single Arm, Phase IIA Clinical Trial Assessing The Safety And Efficacy of Atezolizumab in Combination With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2018
At a glance
- Drugs Atezolizumab (Primary) ; Paclitaxel; Pertuzumab; Trastuzumab
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 07 Jun 2017 Status changed from not yet recruiting to recruiting.
- 07 Jun 2017 Planned initiation date changed from 1 May 2017 to 1 Jul 2017.